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ABSTRACT This review defines bioorganic chemistry as one of the most important constituents of physico-chemical 
biology, which is a fundamental life science. The problems and goals of bioorganic chemistry are examined through a 
comparatively small number of examples. Bioorganic chemistry is supposed to be a logical continuation of the chem-
istry of the natural substances that arose many years ago. Bioorganic chemistry has contributed some achievements in 
solving the problems of the chemical structure, biological function, and physiological activity of biopolymers and low-
molecular-weight bioregulators, as well as in the elucidation of the molecular mechanisms of different life processes. 
The most striking achievements in bioorganic chemistry are discussed in this paper. However, this review discusses not 
only the general achievements in this field of science, but also research data obtained by scientists from the Pacific In-
stitute of Bioorganic Chemistry, Far East Branch, Russian Academy of Sciences (Vladivostok, Russia), and the Institute 
of Physiology, Komi Science Centre, The Urals Branch, Russian Academy of Sciences (Syktyvkar, Russia). Particular 
attention is focused on comprehensive research into polysaccharides and biopolymers (bioglycans) and some natural 
glycosides that the author of this review has studied for a long time. The author has worked in these institutes for a 
long time and was honored by being chosen to head one of the scientific schools in the field of bioorganic chemistry 
and molecular immunology.
KEYWORDS bioglycans, natural glycosides, low-molecular-weight bioregulators.
ABBREVIATIONS LPS – lipopolysaccharide, PSA – prostate specific antigen, LPPC - lipopolysaccharide-protein complex, 
CEA – carcino-embryonic antigen, PC – prostate cancer.
INTRODUCTION
The chemical structure of biopolymers and bioregulators 
with low molecular weight, their biological activity, and their 
role in the organism are what bioorganic chemistry studies. 
Bioorganic chemistry also studies the physiological effects of 
different chemicals isolated from a particular source in a hu-
man or nonhuman organism. According to N.E. Spichenkov 
and V.E. Vas’kovsky [1], the term “bioorganic chemistry” was 
first mentioned in 1967 in an article by M.M. Shemyakin and 
A.S. Khokhlov [2]. All aspects of bioorganic chemistry were 
thoroughly reviewed by Yu.A. Ovchinnikov in his classical 
work [3] widely used by specialists in this scientific field.
Since the middle of the 20th century, bioorganic chemists 
have been interested in marine organisms [4–6], including 
seaweeds, marine animals, and bacteria. Many marine or-
ganisms are sources of unusual secondary metabolites with 
peculiar structures and unique properties [7]. Studies of the 
polysaccharides of seaweeds began in the 19th century and 
successfully continue today [8].
Bioorganic chemistry plays a crucial role in the develop-
ment of pharmacological drugs, nutritional supplements, 
pharmacological chemistry, and medicine. This scientific 
branch rests on the basis of the chemistry of the natural 
compounds used in ethnomedicine, which has existed for 
thousands of years and helps in the choice of biological com-
pounds as origins and sources of valuable biopharmaceuti-
cals, nutritional supplements, and drugs. A detailed review 
of low-molecular-weight bioregulators of different types was 
recently published by scientists from Irkutsk [9–11]. Thus, in 
a historical perspective, a structural analysis of the ginseng 
and trepang extracts [4] used in Chinese medicine as active 
biostimulators shows that both extracts contain similar low-
molecular-weight ingredients (bioregulators), which are trit-
erpene glycosides lacking carbohydrate branches (aglicons 
and genins). Similar compounds were also found in birch and 
alder leaves, which in some cases can serve as raw material 
for the artificial synthesis of an effective agent of ginseng 
(Panax gingeng, C.A. May) and its glycosides (panaxosides) 
(Fig. 1). To trigger the physiological activity of these glyco-
sides, a carbohydrate component (glycon) is needed, and it 
must contain oligosaccharides and comparatively short hy-
drocarbon chains.
PLANTS AND FUNGI POLYSACCHARIDES
Plants are known to contain polysaccharides with long car-
bohydrate chains, linear or branched. Such polysaccharides 
make up 80% of the chemical compounds of the cell. They 
have different functions in the cell; many of them possess a REVIEWS
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marked physiological activity. Physiologically active polysac-
charides contain glycuronic acids in their structure: mainly 
D-galacturonic and D-glucuronic acids. Plant polysaccharides 
such as pectic substances, gums, and mucilages [12, 13] de-
mand special attention. Alginic acid, the main polysaccharide 
of marine brown seaweeds, consists of D-mannuronic and 
L-guluronic acids [14].
For a long period of time, pectic substances, which are 
the principium of so-called plant dietary fibers and biopoly-
mers with high and polypotent biological activity [15], have 
been the object of special attention from researchers. The 
1,4-linked residues of α-D-galacturonic acid form the back-
bone of pectic substances. The linear regions of this chain are 
interlinked by L-rhamnose residues involved into the chain 
by 1,2- α-glycoside linkages. The side chains of different 
lengths are made mainly of the arabinose and galactose resi-
dues which attached to the rhamnose residues. Pectic sub-
stances are considered a complicated polysaccharide complex 
composing the basis of the plant cell and including protopec-
tin, an insoluble pectin complex with cellulose and hemicel-
lulose; pectin polysaccharides of irregular structures; and 
concomitant branched polysaccharides: arabinans, galactans, 
and arabinogalactants (Fig. 2) [16].
A general scheme of pectin polysaccharides is shown in 
Fig. 3 [16, 17].
Pectin polysaccharides were shown to possess a wide spec-
trum of physiological activity [17–19]. Therein, we should 
first mention their immunomodulating effect (phagocytosis 
stimulation); pronounced antiulcerous and antidotal action; 
and the ability to remove salts of heavy metals, organic toxins, 
and poisons from the organism. This is why, in hot shops and 
during chemical production, workers usually receive some 
pectins instead of milk as a preventive antidote. Apple pectins 
are also good for human health. Regular apple consumption 
(one in the morning and one in the evening) can prolong a hu-
man’s life by 10 years. Apple jam is supposed to be healthier 
because of its higher relative pectin content when compared 
to fresh apples. Galacturonans lacking side chains were found 
to possess pronounced antiinflammatory activity [20].
Several fungi should be mentioned, which are the sources 
and origins of other physiologically active polysaccharides. 
Lentinan and pachimaran are of great interest to research-
ers. Lentinan was first isolated by a Japanese research team 
headed by G. Chihara in 1969 [21] from the mushroom Len-
tinus edodes, which is widespread in the Pacific region and 
popular in Japan. Another active fungi glucan, called pachi-
man, was isolated from fungus Poria cocos [22, 23]. The mild 
periodate oxidation of pachiman leads to the generation of 
the more active pachimaran. Moreover, the latter fungus is 
a source of a series of physiologically active 1,3-β-D-glucans 
[24, 25]. Lentinan and pachimaran belong to the group 1,3-β-, 
1,6- β-D-glucans, the backbone of which consists of D-glu-
copyranose residues linked by β-1,3-glycosidic linkages; the 
side chains of β-D-glucopyranose are attached to the back-
bone by the β-1,6-glycoside linkage [21–26].
Both polysaccharides possess high antitumor activity, 
which, as was shown by Chihara and other Japanese re-
searchers, can be explained directly by their immunomodu-
lating effect on the immune system of an organism with a 
tumor [21, 27, 28].
Thus, lentinan almost completely breaks the growth of a 
number of experimental tumors such as Gauss sarcoma, Ehr-
lich carcinoma, etc. Lentinan’s antitumor activity was shown 
to be caused by stimulation of T-lymphocyte killers, while no 
effect on B-lymphocytes and, thus, on the antibody develop-
ment (humoral response) was observed. The high molecular 
weight of the fungi glucans (1 MDa) was shown to be a sig-
nificant factor of their immunomodulating activity. However, 
the partial removal of the side chains of lentinan without a 
significant decrease in its molecular weight failed to affect 
immunomodulating activity; moreover, the transformation 
of pachiman into pachimaran leads to a noticeable increase in 
physiological activity [27].
Lentinan is widely used in medicine as an effective means 
for preventing and curing a number of malignancies.
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The fungi of different species of Ganoderma genus and 
first of all of G. lucidium, which is widely used in ethnomedi-
cine in Japan and China in particular, are widespread sources 
of 1,3-β-D-glucans [29, 30]. Over the last several years, com-
prehensive research into this group of fungi has been car-
ried out [30–35]. 1,3-β-D-glucan was found to be one of the 
main components of G. lucidium [35], which possesses im-
munostimulating activity and, first and foremost, intensified 
phagocytosis and increased interleukin-1 (IL-1) production. 
Moreover, 1,3-β-D-glucans were shown to increase the pro-
duction of an intensive immunomodulator, interferon (IFN-γ) 
[36]. Therefore, fungus extracts are used to cure the impaired 
immune system, digestive tract ulcer, and cancer. A prepara-
tion based on the dry powder of G. lucidium, particularly, is 
used to cure sarcoma [37].
Moreover, lanostanic triterpenoids found and isolated from 
different species of fungi [38, 39], ganodermic acid in par-
ticular, are being studied (Fig. 4). The presence of ganoder-
mic acid in the aqueous ethanolic extract of G. lucidium was 
found to cause various physiological activities. The Ling-Zhi 
preparation based on G. lucidium (aqueous ethanolic extract) 
produced in China is used to cure nerve diseases, insomnia, 
vertigo, asthma, and other allergic manifestations [39].
A large body of data concerning the structure and physi-
ological activity of 1,3-β-D-glucans from a number of fungi 
has been accumulated over the last several years [40–43].
BIOGLYCANS OF MARINE INVERTEBRATES
The substantial bioglycan group of immunomodulators rep-
resenting carbohydrate-protein biopolymers with a branched 
D-glucan was isolated from marine invertebrates. Branched 
D-glucan forms stable noncovalent bonds with the protein 
component representing lectin, which specifically binds 
polysaccharides. Immunomodulating activity was shown to 
need the presence of both bioglycan constituents [44, 45].
We have systematically studied many different marine in-
vertebrates [45], and almost all of them were found to contain 
immunomodulating bioglycans. Our results led us to conclude 
that marine invertebrates produce immunomodulating bi-
oglycans, which are responsible for their well-known resist-
ance to arising neoplasma [45].
Mytilan is the most thoroughly studied immunomodulat-
ing bioglycan; it is isolated from different species of mussels of 
the Mytilidae family (Crenomytilus grayanus, Mytilus edulis, 
and M. galloprovinciales), which are widespread in the seas 
[44, 45]. Mytilan significantly increases phagocytic activity 
and factors of the humoral immunity. This substance is ob-
tained from the so-called mussel juice, which was considered 
as waste in processing mussel as food stuff [6, 44, 45].
The property of mytilan behind the increase in the im-
mune response to influenza has attracted the most interest. 
Because of that, mytilan has been widely used for influenza 
prevention and curation, especially at the early stage of the 
disease. The antiviral effect of mytilan is due to its ability to 
increase the biosynthesis of endogenous interferon, which 
plays a determinative role in the organism’s resistance to vi-
ral infection. Interestingly, mytilan has been found to double 
the mean lifetime of experimental animals [6, 45].
LYPOPOLYSACCHARIDES OF GRAM-NEGATIVE BACTERIA 
Since the middle of the 1930s, the attention of researchers 
has focused studies of the structural features and physiologi-
cal activity of the antigens of gram-negative bacteria, the so-
called O-somatic antigens, representing lipopolysaccharides 
(LPS) [46].
In the beginning, the French scientists A. Boivin and 
L. Mesrobeanu [47] isolated the immunogenic lipopolysac-
charide-protein complex (LPPC) which is known up to now 
as the Boivin antigen [48]. Later, a huge number of works 
were devoted to the study of the structure and properties 
of LPS, which were not only O-somatic antigens of gram-
negative bacteria, but also active endotoxins [49]. LPS were 
found to consist of three main regions bound to each other 
as follows:
Lipid A – Core of the macromolecule – O-Specific polysac-
charide.
A significant contribution to the study of the structure and 
properties of LPS has been made by the German Westphal-
Luderitz school in Freiburg (FRG) since the 20th century. 
Since the 1960s, studies of the structure and properties of 
LPS have multiplied. In 1970 [50] at the Pacific Institute for 
Bioorganic Chemistry (Vladivostok), we started studying 
the antigenic composition of the pseudotuberculous microbe 
Yersinia pseudotuberculosis which causes a specitic disease, 
the so-called Far East scarlatinous fever (in Primorsky re-
gion). Research of LPS continues up to now. The most well-
known works devoted to the study of LPS were carried out 
by the N.K. Kochetkov’s scientific school [51] especially by his 
pupil Yu.A. Knirel [52].
The structural features of the numerous LPS of gram-
negative bacteria have been elucidated as a resut of these 
Research. Lipid A was shown to be responsible for the endo-
toxic properties of LPS, namely to cause the main symptoms 
of various diseases. The pattern of the immune response is 
determined by the O-specific polysaccharide, which is a ma-
trix for the antibody production and differentiation. There-
fore, this polysaccharide is in charge of the organism’s im-
mune response during the development of the disease. The 
structure of O-specific polysaccharides can vary significantly. 
They have been found to contain the residues of many unu-
sual monosaccharides. Such monosaccharides are often lo-
cated at the terminal points of the macromolecule, and they 
determine its serospecificity, being immunodeterminant or 
immunodominant sugars [51–53].
As a rule, LPSs are not used for curation because of their 
high toxicity and, thus, low therapeutic index. However, on 
the basis of LPSs, many diagnostic techniques have been de-
veloped which make it possible to diagnose a disease at the 
earliest stage. Moreover, O-specific polysaccharides often 
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possess an immunoadjuvant property; i.e., they can boost the 
effect of a vaccine against a certain disease [52, 54].
The LPSs of blue-green algae known also as  cyanobac-
teria appear to hold much promise. Such LPSs are nontoxic, 
while they possess pronounced immunoadjuvant properties; 
on their basis we developed a powerful adjuvant lacking the 
side effects characteristic of classic adjuvants, such as the 
Freund’s adjuvant, which often causes abscess to develop at 
the injection site [55].
ONCOFETAL ANTIGENS
The oncofetal antigens discovered by Yu.S. Tatarinov and 
G.I. Abelev in the beginning of the 1960s [56, 57] are of great 
research interest today [58–61]. Oncofetal antigens appear in 
the human organism during prenatal development, making 
the organism tolerant to these antigens. Later, they disappear 
and can appear again only during the development of an on-
cological disease. Thus, the cancer cell hides from the immune 
system of the host organism, which in this case cannot recog-
nize the cancer cell as a foreign antigen. Therefore, oncofetal 
antigens are important markers of cancer (neoplasma) and 
are used to reveal tumors at the early stages of their develop-
ment [44, 62, 63].
In this relation, the carcino-embryonic antigen (CEA) [63, 
64], which does not differ in high specificity and is not re-
vealed in the bodily fluids of a healthy human, is of great in-
terest. Its appearance and accumulation in blood (more than 
5 ng/ml) evidence the presence of almost any oncological 
disease in the organism, like neoplasias of the digestive tract 
and respiratory system or carcinoma of the breast, head, or 
neck [63]. Like all the oncofetal antigens CEA is a complicated 
glycoprotein, the protein part of which plays the determina-
tive role. A study of its spatial structure showed that the car-
bohydrate moiety stabilizes the CEA conformation [64, 65].
It should be noted that many oncofetal antigens possess 
high enough, although not absolute specificity. Among them, 
the prostate-specific antigen (PSA) is one of the main mark-
ers of prostate cancer (PC), namely adenocarcinoma of pros-
tate [66]. The PC is a male tumor, hormone-dependent at its 
early stages (androgen-dependent) [67–70], and widespread 
among men (second after lung cancer). Later, PC transforms 
into an androgen-independent metastasizing stage. Its lethali-
ty is usually due to metastases in bones and lymphnodes, as 
well as to switch of the tumor into the androgen-independent 
stage of tumor growth, which aggravates the process curing 
PC. Any effective curation of PC with metastases is absent in 
the present time. This disease is especially widespread among 
men in the United States. Official data show that PC was re-
sponsible for the death of more than 37,000 men in 1999 and 
about 30,000 men in 2005 in the U.S.A. Studies of PC are be-
ing pursued intensively there. An analysis of the PSA level in 
blood is widely used for PC diagnostics. Though this test often 
yields a false-positive reaction, it accurately determines the 
risk level. PSA is a single-stranded glycoprotein containing 
240 a.a. with a molecular weight of 33–34 kDa [66]. There are 
several markers for the existence of PC, nevertheless an ex-
act diagnosis remains difficult, although modern techniques 
for measuring PSA in blood have recently been developed 
[71–73].
A cure for PC includes a sharp increase in physical activ-
ity, leading to the normalization of metabolic processes and to 
decongestion [69, 71]. Pharmaceutical treatment is based on 
the use of antioxidants, anti-inflammatory compounds, and 
antiandrogens (Fig. 5) inhibiting testosterone transformation 
into dihydrotestosteron. Antiandrogens are important when 
curing at the first androgen-dependent stage of the disease 
[66, 74–79].
Strategies for curing any tumor, PC in particular, include 
the wide use of antioxidants. Increased oxygen consumption 
is a characteristic of tumor cells. Therefore, antioxidants, for 
instance, apigenin, an active component of green tea, effec-
tively block tumor development (Figs. 6, 7).
Licopene (Fig. 7), a lipophilic hydrocarbon with a linear 
chain consisting of 40 carbon atoms and containing 11 conju-
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gated and 2 nonconjugated olefinic linkages, possesses high 
antitumor activity [80]. Fresh tomatoes contain the licopene 
trans-form, which, after the tomatoes are processed, trans-
forms into the cis-form. Licopene bioavailability for humans 
is 2.5-fold higher in tomato paste when compared to fresh 
tomatoes. Tomato consumption decreases the PC risk by 20%, 
while the use of tomato paste or tomato sauce leads to a 66% 
decline of this parameter. Therefore, the consumption of food 
containing tomato significantly decreases the risk of PC. Si-
multaneously, the cancer risk in the digestive tract, lung, and 
breast also declines [80].
Licopene has been shown to be an antioxidant and pos-
sesses a protective effect against lipid peroxygenation and 
DNA oxidative cleavage. These properties are behind the 
protective role played by licopene against tumors [81]. Lico-
pene is used in medicine as a component of biologically active 
supplements such as licoprophit and licolam.
Thus, a number of medications exist that are used for cur-
ing oncological diseases. Many of them were offered by experts 
in bioorganic chemistry. However, more than any medications, 
the desire of a patient to resist the disease, constant cheertul 
mood, and an active way of life (which promotes metabolism 
normalization and intensifies immunity) are the main factors 
enhancing the organism’s resistance to oncological diseases.
ACTIVE COMPONENTS OF GARLIC
Garlic, Allium sativum L. (Fig. 8), contains very interesting 
compounds with different physiological functions [82]. The 
average content of alliin, a sulfoxide S(+)-alkyl-L-cystein, 
is about 2%. Alliin possesses a marked physiological action 
against gastric ulcer and is useful for curing oncological dis-
eases due to its anti-inflammatory activity.
However, garlic contains about 3% of a highly active en-
zyme, alliinase, which strongly intensifies in the presence 
of atmospheric oxygen, as was demonstrated by Japanese 
researchers [83]. This explains the fast alliin digestion on 
grinding garlic leading to allicin and the formation of other 
sulphur compounds, which are responsible for the specific 
smell and taste of garlic. These compounds possess a powerful 
bactericidal effect against gram-positive (e.g., Staphylococ-
cus aureus) and gram-negative (e.g., Salmonella sp.) micro-
organisms, but they markedly irritate mucous membranes 
and are contraindicated in case of gastric ulcer [83]. Sulphur 
compounds were also shown to decrease carcinogen-induced 
cancer development in several organs due to their high anti-
oxidative activity and ability to stimulate the immune re-
sponse [84].
FLAVONOIDS AND ALKALOIDS
Flavonoids are a large class of active natural compounds 
widespread in the plant world. They appear to be different 
derivatives of chromane and isochromane and are found in 
nature as glycosides and aglycons [9–11].
Quercetin bioside (Fig. 9), called rutin after the plant rue 
from where it was first isolated, can be such an example [9, 10]. 
Rutinose, a disaccharide, is a constituent of rutin. Rutin was 
isolated from buckwheat leaves and belongs to the group P of 
vitamins. In the mammalian organism, rutin strengthens blood 
capillaries and increases blood coagulation. The presence of the 
vitamin C increases the effect of rutin. Rutin is used for cur-
ing diseases connected with blood strokes caused by increased 
capillary fragility and a defect in the blood coagulation system. 
Such a physiological action is characteristic of many flavonoids, 
which more or less possess P-vitamin activity.
Flavonoids are powerful antioxidants and can bind free 
radicals damaging the cell walls of normal cells.
Of all the other low-molecular-weight bioregulators, only 
alkaloids will be mentioned [3], which are various, highly ac-
tive compounds containing nitrogen. Many of them are strong 
narcotics and analgesics. Morphine (Fig. 10), the main alkaloid 
of the poppy (Papaver somniferum), is one of the most famous 
alkaloids [3, 85]. Bioorganic chemists have elucidated not only 
the structure of this very complicated natural compound, but 
also succeeded in synthesizing it. In addition, ajmaline and al-
lopinine are alkaloids with a strong antiarrhythmic effect.
POISONS AND TOXINS
Poisons and toxins, small doses of which cause the death of 
an organism, possess the highest physiological activity. The 
terms poison and toxin are very similar, though poisons are 
Alliin (2%)
Does not smell and possesses 
antiulcer and antitumoral action 
(anti-inflammatory activity)
Possesses a specific garlic taste and 
smell (contraindicitive in the case 
of ulcers)
S (+) alkyl-L-cysteine 
sulphoxide
Alliinase (3%)
Allicine
Z-4,5,9-triadodeca-1,6,11-
trien-9-oxide
E-4,5,9-tritiadodeca-1,6,11-
trien-9-oxide
O
O
O O
S
S
S
S
S
S S S
S
NH2
COOH
Possesses a powerfull bactericidal effect against gram-positive and 
gram-negative bacteria.
Fig. 8. Active components of garlic (Allium sativum L.).
O
O
HO
OH
OH
OH
O-β-D-Glcp←
6α-L-Rhap
Fig. 9. Rutin (vita-
min P), quercetin’s 
rutinoside.
HO
HO
O H H
NCH3
Fig. 10. Morphine, poppy (Papaver 
somniferum) alkaloid, strong narcotic, 
and powerful analgesic.REVIEWS
 VOL. 2  № 2 (5)  2010  | ACTA NATURAE | 33
any toxic substance irrespective its origin, e.g., cianide, ar-
senic, and cobra poison. Toxins are poisons of a biological na-
ture only [3].
Poisons and toxins are substances of the highest physiolog-
ical activity and selectivity. Botulinotoxin, the protein toxin 
of the anaerobic bacteria Clostridium botulinum, is the most 
toxic among poisons and toxins [3, 86]. Other clostridium tox-
ins possess the same high toxicity. A lethal dosage of botuli-
notoxin is equal to 10-5 μg/kg, while the toxicity of potassium 
cyanide is 104 μg/kg. Botulinotoxin is synthesized by clostridia 
in strictly anaerobic conditions. This is a powerful neurotoxin 
blocking the transduction of neural impulses, which leads to 
paralysis and death. Humans and domestic animals are the 
most sensitive subjects to botulinotoxin. Humans are usu-
ally affected by botulinotoxin after eating poorly preserved 
food, like meat; fish; and, more frequently, agarics. Clostrid-
ium endospores are well preserved on unpeeled mushrooms. 
Endospores are stable to the tough condition of sterilization. 
During home conservation, conditions are often nonsterile, 
which promotes the survival and reproduction of clostridium 
endospores in an anaerobic medium, leading to the generation 
of the active form of clostridia, which produces botulinotoxin. 
Botulism is a severe disease and leads to death. This is why 
buying canned mushrooms of unknown origin and eating 
underboiled preserved mushrooms are not recommended. It 
is recommended to boil even homemade canned goods be-
fore eating to destroy the synthesized botulinotoxin in case it 
formed in the conserved product. Using anatoxin, i.e. a toxin 
treated previously with formalin, or using a serum against 
anatoxin gives good results in curing botulism at all stages of 
the disease’s development.
Cyclopeptide toxins of the death cup Amanita phalloides 
[3, 76], amanitine and phalloidin, are other powerful toxins of 
a protein nature which were first isolated as individual sub-
stances in 1937 by the German researchers F. Linen and G. 
Viland. Poisoning by death cup toxins is widespread. These 
toxins are distinguished by their prolonged latent period (up 
to 36 hours) as the liver is painlessly destroyed. By the time 
the symptoms emerge, any kind of cure appears to be inef-
fective, which explains the high percentage of mortality by 
intoxication. Interestingly, eating even one death cup can 
be fatal. At the same time, the death cup contains peptide 
antamadine, a 1 mg/kg concentration of which protects the 
organism from the destructive action of the toxin. Hepatopro-
tective medication (carsil, isolated from Silybum marianum 
and available in any pharmacy) has a positive effect, which is 
especially preventive against amanitine intoxication.
Among the nonprotein toxins, we will mention shortly tox-
ins produced by marine organisms.
Tetrodotoxin, contained in fish of the Tetraodontidae fam-
ily (Fig. 11), is one of the most well-known nonprotein toxins. 
The most famous of the family goes by the names hogfish, 
swell fish, or puffer fish Fugu niphobles and F. rubripes. Tet-
rodotoxin was also isolated from the Corsican frog Atelopus 
sp., the crab Atergatis floridis, and the Californian triton 
Taricha torosa.
The puffer fish is considered a delicacy in Japan. Tetrodo-
toxin is accumulated in different fugu organs, but mainly in 
roe, liver, and skin. Special chefs carefully remove these or-
gans before cooking. However, in some seasons, tetrodotoxin 
accumulates in all of the fugu body, making it completely 
toxic, which often leads to fatal consequences. In some years, 
hundreds of people die in Japan after eating puffer fish. This 
is why the puffer fish is served only in special restaurants 
displaying signs that read “Want to try fugu? Write your last 
will.”
Tetrodotoxin is a powerful neurotoxin causing the paraly-
sis of human and mammalian skeletal muscle, a sharp decline 
in blood pressure, and death by respiratory arrest. The lethal 
dosage is equal to 7 μg/kg.
Tetrodotoxin is widely used in laboratory practice to study 
the mechanisms of neural transduction.
Palytoxin is another nonprotein toxin of marine origin with 
a complicated structure (Fig. 12). It was first isolated in 1971 
by the American scientists R.E. Moore and P. Scheuer [87] 
from the soft corall Polytoa toxica. The results of numerous 
studies of palytoxin have been described in a detailed review 
[88]. While the toxin was being isolated by Drs. Moore and 
Scheuer, a conflagration appeared in the laboratory. Eve-
rybody who dealt with the toxin suffered; particularly the 
cardiovascular system of the researchers was injured. Con-
sequently, this powerful toxin was named “messenger of Sa-
tan.” The complex structure of palytoxin was determined a 
decade later, in 1981, by two independent research groups, 
one from Japan headed by Prof. Y.Hirata [89, 90] and another 
by Prof. R.E. Moore [91]. The determination of the palytoxin 
structure became a significant event in bioorganic chemistry. 
Its molecule possesses a unique structure [3] (Fig. 12). A stere-
ochemical study of palytoxins was successfully carried out by 
the above-mentioned groups of Japanese and American re-
searchers [92, 93]. In spite of the existence of a huge number 
of possible stereoisomers, a group of Japanese researchers 
headed by Prof. Y. Kishi [94] in 1989 successfully synthesized 
several palytoxin derivatives. A comparison with the natural 
palytoxin showed that synthetic substances were identical to 
natural ones in biological activity, chromatographic behavior, 
and spectral characteristics obtained by NMR spectroscopy 
and mass spectrometry [94]. Several years later, in 1994, a 
palytoxin specimen completely identical to the natural one 
was synthesized [95]. However, the complete chemical syn-
thesis of palytoxins includes 65 stages [96], which makes it 
impossible to use in every day practice. The physiological ac-
tion of palytoxin is quite significant [3]; being injected intra-
venously, it is LD50 = 0.15 μg/kg for mice and 0.08 μg/kg for 
monkeys. The lethal outcome takes 5–30 minutes as a result 
of deep injury to the cardiovascular system and respiratory 
arrest. The toxic dose for different animals varies from 0.01 
to 0.1 μg/kg of LD50 [96]. The toxic dose for human was not 
measured experimentally of course, though an extrapolation 
of the data obtained in studies on different animals makes it 
possible to conclude that it takes LD50 of about 0.04 μg/kg [97]. 
In spite of the high toxicity, palytoxin was found in a number 
of marine invertebrates [88, 97]. Interestingly, palytoxin in 
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the sublethal dose demonstrated a high antitumoral activity.
In tropical seas, “red tides” are often observed causing the 
massive death of various marine organisms as a result of the 
intensive multiplication of toxic microalgae (dinoflagellates). 
These microalgae release a number of strong toxins, including 
the most powerful of the known nonprotein toxins, maitotox-
in [98]. This toxin was first found in 1976 [99] in the intestine 
of the surgeonfish Ctenochaetus striatus as the main compo-
nent of siguatera, the famous food toxin of dinoflagellates 
Gambierdicus toxicus, which is included in the food chain of 
herbivorous fish. The toxicity of maitotoxin is the highest, 
LD50 is equal to near 0.05 μg/kg for mice. Maitotoxin was first 
isolated as an individual substance in 1988 by a group of Japa-
nese researchers headed by Prof. T. Yasumoto from Tochoku 
University [100]. The structure of this complicated substance, 
including the elements of stereochemistry, was elucidated in 
1992–1994 [101] by this research group using spectral analy-
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sis, NMR spectroscopy, and mass spectrometry techniques, in 
particular. They also determined the absolute configuration 
of maitotoxin in 1996 [102]. The data obtained were confirmed 
later, when maitotoxin was artificially synthesized by a group 
of Japanese scientists headed by Y. Kishi [103].
These data demonstrate clearly that bioorganic chemistry 
has assumed a prominent place among the sciences that study 
basic life processes and the substances playing an active role 
in those processes. Bioorganic chemists continue to study the 
chemical structure of new biopolymers and low-molecular-
weight bioregulators and to shed light on their biological 
functions and physiological activity. Special attention is fo-
cused on unveiling the interrelations between the structural 
features and biological activities of different chemical sub-
stances. Bioorganic chemists, together with biochemists, bio-
technologists, physiologists, and doctors, are obtaining new 
results that help extend productive human life. 
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